vs
Can-Fite BioPharma Ltd.（CANF）与法拉第未来（FFAI）财务数据对比。点击上方公司名可切换其他公司
Can-Fite BioPharma Ltd.的季度营收约是法拉第未来的1.6倍（$202.0K vs $129.0K），Can-Fite BioPharma Ltd.净利率更高（-2413.9% vs -26011.6%，领先23597.8%），Can-Fite BioPharma Ltd.同比增速更快（-36.1% vs -45.1%），Can-Fite BioPharma Ltd.自由现金流更多（$-4.8M vs $-29.5M）
Can-Fite BioPharma是一家处于临床阶段的生物制药企业，专注于开发靶向腺苷受体的专利小分子疗法，管线覆盖肿瘤、炎症性疾病、肝脏疾病等领域的未满足医疗需求，面向全球医疗市场开展业务。
法拉第未来是2014年成立的美国科技企业，总部位于加利福尼亚州洛杉矶，核心业务为研发电动汽车，2023年正式投入量产，产品在中美两国市场销售。截至2025年1月，该公司累计交付16辆汽车。2024年末完成两轮合计6000万美元融资后，法拉第未来宣布将转型销售贴牌中国厢式车。
CANF vs FFAI — 直观对比
营收规模更大
CANF
是对方的1.6倍
$129.0K
营收增速更快
CANF
高出9.0%
-45.1%
净利率更高
CANF
高出23597.8%
-26011.6%
自由现金流更多
CANF
多$24.8M
$-29.5M
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $202.0K | $129.0K |
| 净利润 | $-4.9M | $-33.6M |
| 毛利率 | — | -12111.6% |
| 营业利润率 | -2424.8% | -25041.9% |
| 净利率 | -2413.9% | -26011.6% |
| 营收同比 | -36.1% | -45.1% |
| 净利润同比 | -23.2% | 72.3% |
| 每股收益（稀释后） | $0.00 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CANFFFAI
| Q4 25 | — | $129.0K | ||
| Q2 25 | $202.0K | — | ||
| Q1 25 | — | $316.0K | ||
| Q4 24 | — | $235.0K | ||
| Q2 24 | $316.0K | $293.0K | ||
| Q4 23 | — | $233.0K | ||
| Q3 23 | — | $551.0K | ||
| Q2 23 | — | $0 |
净利润CANFFFAI
| Q4 25 | — | $-33.6M | ||
| Q2 25 | $-4.9M | — | ||
| Q1 25 | — | $-10.3M | ||
| Q4 24 | — | $-121.3M | ||
| Q2 24 | $-4.0M | $-108.7M | ||
| Q4 23 | — | $-83.8M | ||
| Q3 23 | — | $-78.0M | ||
| Q2 23 | — | $-124.9M |
毛利率CANFFFAI
| Q4 25 | — | -12111.6% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -6666.1% | ||
| Q4 24 | — | -8801.7% | ||
| Q2 24 | — | -7057.0% | ||
| Q4 23 | — | -8424.9% | ||
| Q3 23 | — | -2827.6% | ||
| Q2 23 | — | — |
营业利润率CANFFFAI
| Q4 25 | — | -25041.9% | ||
| Q2 25 | -2424.8% | — | ||
| Q1 25 | — | -13870.6% | ||
| Q4 24 | — | -12899.6% | ||
| Q2 24 | -1295.6% | -17272.7% | ||
| Q4 23 | — | -29090.1% | ||
| Q3 23 | — | -12059.3% | ||
| Q2 23 | — | — |
净利率CANFFFAI
| Q4 25 | — | -26011.6% | ||
| Q2 25 | -2413.9% | — | ||
| Q1 25 | — | -3252.5% | ||
| Q4 24 | — | -51599.6% | ||
| Q2 24 | -1252.2% | -37093.9% | ||
| Q4 23 | — | -35964.4% | ||
| Q3 23 | — | -14164.4% | ||
| Q2 23 | — | — |
每股收益（稀释后）CANFFFAI
| Q4 25 | — | — | ||
| Q2 25 | $0.00 | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q2 24 | $0.00 | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.5M | $34.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $4.2M | $-27.3M |
| 总资产 | $7.7M | $277.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CANFFFAI
| Q4 25 | — | $34.9M | ||
| Q2 25 | $6.5M | — | ||
| Q1 25 | — | $9.5M | ||
| Q4 24 | — | $7.1M | ||
| Q2 24 | $4.7M | $793.0K | ||
| Q4 23 | — | $1.9M | ||
| Q3 23 | — | $6.7M | ||
| Q2 23 | — | $17.9M |
股东权益CANFFFAI
| Q4 25 | — | $-27.3M | ||
| Q2 25 | $4.2M | — | ||
| Q1 25 | — | $139.8M | ||
| Q4 24 | — | $115.0M | ||
| Q2 24 | $2.5M | $148.7M | ||
| Q4 23 | — | $228.2M | ||
| Q3 23 | — | $261.8M | ||
| Q2 23 | — | $277.7M |
总资产CANFFFAI
| Q4 25 | — | $277.9M | ||
| Q2 25 | $7.7M | — | ||
| Q1 25 | — | $410.6M | ||
| Q4 24 | — | $425.4M | ||
| Q2 24 | $5.9M | $457.9M | ||
| Q4 23 | — | $530.5M | ||
| Q3 23 | — | $579.5M | ||
| Q2 23 | — | $567.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.8M | $-28.4M |
| 自由现金流经营现金流 - 资本支出 | $-4.8M | $-29.5M |
| 自由现金流率自由现金流/营收 | -2353.0% | -22886.8% |
| 资本支出强度资本支出/营收 | 0.5% | 867.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-91.3M |
8季度趋势，按日历期对齐
经营现金流CANFFFAI
| Q4 25 | — | $-28.4M | ||
| Q2 25 | $-4.8M | — | ||
| Q1 25 | — | $-20.3M | ||
| Q4 24 | — | $-18.4M | ||
| Q2 24 | $-4.0M | $-14.4M | ||
| Q4 23 | — | $-37.8M | ||
| Q3 23 | — | $-79.7M | ||
| Q2 23 | — | $-57.7M |
自由现金流CANFFFAI
| Q4 25 | — | $-29.5M | ||
| Q2 25 | $-4.8M | — | ||
| Q1 25 | — | $-21.9M | ||
| Q4 24 | — | $-25.3M | ||
| Q2 24 | $-4.0M | $-14.6M | ||
| Q4 23 | — | $-58.1M | ||
| Q3 23 | — | $-94.7M | ||
| Q2 23 | — | $-66.7M |
自由现金流率CANFFFAI
| Q4 25 | — | -22886.8% | ||
| Q2 25 | -2353.0% | — | ||
| Q1 25 | — | -6918.7% | ||
| Q4 24 | — | -10770.6% | ||
| Q2 24 | -1278.5% | -4993.5% | ||
| Q4 23 | — | -24923.2% | ||
| Q3 23 | — | -17181.1% | ||
| Q2 23 | — | — |
资本支出强度CANFFFAI
| Q4 25 | — | 867.4% | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | — | 496.2% | ||
| Q4 24 | — | 2945.1% | ||
| Q2 24 | 1.3% | 88.4% | ||
| Q4 23 | — | 8696.6% | ||
| Q3 23 | — | 2723.4% | ||
| Q2 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
